Recent Finacing
Recent Raise
PACT Pharma develops neoantigen-specific T cell receptor therapies, advancing TCR programs, building in-house manufacturing capabilities, and expanding executive leadership to support clinical and technical development.
Focus Areas
Recent Investors
Total Raised
Funding round
See the team members at PACT Pharma.
